BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
Clinical trial NCT01354431 · COMPLETED
Trial details
- NCT number
- NCT01354431
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-31
- Primary completion
- 2013-05-15
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.